- Home
- SABR vs MPLT Comparison
SABR vs MPLT Comparison
Compare SABR & MPLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SABR | MPLT |
|---|---|---|
| Founded | 2006 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 627.9M | 594.8M |
| IPO Year | 2014 | 2025 |
Fundamental Metrics
Financial Performance| Metric | SABR | MPLT |
|---|---|---|
| Price | $1.65 | $18.34 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 4 |
| Target Price | $4.12 | ★ $31.00 |
| AVG Volume (30 Days) | ★ 5.4M | 259.6K |
| Earning Date | 11-05-2025 | 12-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 1.41 | N/A |
| Revenue | ★ $3,034,040,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $3.88 | N/A |
| P/E Ratio | $1.18 | ★ N/A |
| Revenue Growth | ★ 8.86 | N/A |
| 52 Week Low | $1.52 | $12.24 |
| 52 Week High | $4.63 | $20.86 |
Technical Indicators
Market Signals| Indicator | SABR | MPLT |
|---|---|---|
| Relative Strength Index (RSI) | 45.08 | N/A |
| Support Level | $1.57 | N/A |
| Resistance Level | $1.64 | N/A |
| Average True Range (ATR) | 0.08 | 0.00 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 65.96 | 0.00 |
Price Performance
Historical ComparisonAbout SABR Sabre Corporation
Sabre holds the number-two air booking volume share in the global distribution system industry. The travel solutions segment represented 91% of total 2024 revenue, split between distribution (79% of segment sales) and airline IT solutions (21%) revenue. The company sold its growing hotel IT solutions division (9% of revenue) to TPG in 2025 for $960 million in net proceeds. Transaction fees, which are mostly tied to volume and not price, account for the bulk of sales and profits.
About MPLT MapLight Therapeutics Inc. Common Stock
MapLight Therapeutics Inc is a biopharmaceutical company. The company is focused on improving the lives of patients suffering from debilitating central nervous system, or CNS, disorders. The company is engaged in psychiatry and neuroscience research to address the lack of circuit-specific pharmacotherapies available for patients. The product candidates of the company include ML-007C-MA, ML-004, ML-021, ML-009, and other pipeline products.